Aurobindo Pharma Ltd.
AGMAug. 29, 2024, 3:30 p.m.
Sr noTypeResolutionIiAS View
1OrdinaryAdoption of standalone financial statements for the year ended 31 March 2024
2OrdinaryAdoption of consolidated financial statements for the year ended 31 March 2024
3OrdinaryConfirm first interim dividend of Rs. 3.0 per equity share (face value of Re. 1.0) and second dividend of Rs. 1.5 per equity share as final dividend for FY24
4OrdinaryReappoint K. Nithyananda Reddy (DIN: 01284195) as Director, liable to retire by rotation
5OrdinaryReappoint M. Madan Mohan Reddy (DIN: 01284266) as Director, liable to retire by rotation
6OrdinaryReappoint K. Nithyananda Reddy (DIN: 01284195) as Vice Chairperson and Managing Director for three years from 1 June 2024 and fix his remuneration
7OrdinaryReappoint M. Madan Mohan Reddy (DIN: 01284266) as Whole-time Director for three years from 1 June 2024 and fix his remuneration
8OrdinaryApprove continuation of P. V. Ramprasad Reddy (DIN: 01284132) as Non-Executive Non-Independent Director, not liable to retire by rotation
9OrdinaryApprove remuneration of Rs. 650,000 payable to EVS & Associates as cost auditors for FY25
10SpecialApprove payment of commission to Independent Directors not exceeding 1% of net profits or Rs. 2.0 mn per independent director from 1 April 2024 onwards


Enter your details


Summary

Particulars
Meeting Report
+ GST @ 18%
Amount
₹ 8,474
₹ 1,526

Total
₹ 10,000